Alteration of Mevalonate Pathway in Proliferated Vascular Smooth Muscle from Diabetic Mice: Possible Role in High-Glucose-Induced Atherogenic Process

The proliferation of vascular smooth muscle cells (VSMCs) is one of the main features of atherosclerosis induced by high glucose. Mevalonate pathway is an important metabolic pathway that plays a key role in multiple cellular processes. The aim of this study was to define whether the enzyme expressi...

Full description

Saved in:
Bibliographic Details
Main Authors: Guo-Ping Chen, Xiao-Qin Zhang, Tao Wu, Liang Li, Jie Han, Chang-Qing Du
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2015/379287
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564971451449344
author Guo-Ping Chen
Xiao-Qin Zhang
Tao Wu
Liang Li
Jie Han
Chang-Qing Du
author_facet Guo-Ping Chen
Xiao-Qin Zhang
Tao Wu
Liang Li
Jie Han
Chang-Qing Du
author_sort Guo-Ping Chen
collection DOAJ
description The proliferation of vascular smooth muscle cells (VSMCs) is one of the main features of atherosclerosis induced by high glucose. Mevalonate pathway is an important metabolic pathway that plays a key role in multiple cellular processes. The aim of this study was to define whether the enzyme expression in mevalonate pathway is changed in proliferated VSMCs during atherogenic process in diabetic mice. Diabetes was induced in BALB/c mice with streptozotocin (STZ, 50 mg/kg/day for 5 days). Induction of diabetes with STZ was associated with an increase of lesion area and media thickness after 8 and 16 weeks of diabetes. In aorta, there were overexpressions of some enzymes, including 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGR), farnesyl pyrophosphate synthase (FPPS), geranylgeranyl pyrophosphate synthase (GGPPS), farnesyltransferase (FNT), and geranylgeranyltransferase-1 (GGT-1), and unchanged expression of squalene synthase (SQS) and phosphor-3-hydroxy-3-methylglutaryl-coenzyme A reductase (P-HMGR) in 8 and 16 weeks of diabetes. In vitro, VSMCs were cultured and treated with different glucose concentrations for 48 h. High glucose (22.2 mM) induced VSMC proliferation and upregulation of HMGR, FPPS, GGPPS, FNT, and GGT-1 but did not change the expressions of SQS and P-HMGR. In conclusion, altered expression of several key enzymes in the mevalonate pathway may play a potential pathophysiological role in atherogenic process of diabetes macrovascular complication.
format Article
id doaj-art-814bd1afd6874925a4dedf7bae49dcb7
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-814bd1afd6874925a4dedf7bae49dcb72025-02-03T01:09:43ZengWileyJournal of Diabetes Research2314-67452314-67532015-01-01201510.1155/2015/379287379287Alteration of Mevalonate Pathway in Proliferated Vascular Smooth Muscle from Diabetic Mice: Possible Role in High-Glucose-Induced Atherogenic ProcessGuo-Ping Chen0Xiao-Qin Zhang1Tao Wu2Liang Li3Jie Han4Chang-Qing Du5Department of Endocrinology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, ChinaDepartment of Respirology, Zhejiang Provincial People’s Hospital, Hangzhou 310014, ChinaInstitute of Cardiology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, ChinaInstitute of Cardiology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, ChinaInstitute of Cardiology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, ChinaDepartment of Cardiology, Zhejiang Hospital, Hangzhou 310003, ChinaThe proliferation of vascular smooth muscle cells (VSMCs) is one of the main features of atherosclerosis induced by high glucose. Mevalonate pathway is an important metabolic pathway that plays a key role in multiple cellular processes. The aim of this study was to define whether the enzyme expression in mevalonate pathway is changed in proliferated VSMCs during atherogenic process in diabetic mice. Diabetes was induced in BALB/c mice with streptozotocin (STZ, 50 mg/kg/day for 5 days). Induction of diabetes with STZ was associated with an increase of lesion area and media thickness after 8 and 16 weeks of diabetes. In aorta, there were overexpressions of some enzymes, including 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGR), farnesyl pyrophosphate synthase (FPPS), geranylgeranyl pyrophosphate synthase (GGPPS), farnesyltransferase (FNT), and geranylgeranyltransferase-1 (GGT-1), and unchanged expression of squalene synthase (SQS) and phosphor-3-hydroxy-3-methylglutaryl-coenzyme A reductase (P-HMGR) in 8 and 16 weeks of diabetes. In vitro, VSMCs were cultured and treated with different glucose concentrations for 48 h. High glucose (22.2 mM) induced VSMC proliferation and upregulation of HMGR, FPPS, GGPPS, FNT, and GGT-1 but did not change the expressions of SQS and P-HMGR. In conclusion, altered expression of several key enzymes in the mevalonate pathway may play a potential pathophysiological role in atherogenic process of diabetes macrovascular complication.http://dx.doi.org/10.1155/2015/379287
spellingShingle Guo-Ping Chen
Xiao-Qin Zhang
Tao Wu
Liang Li
Jie Han
Chang-Qing Du
Alteration of Mevalonate Pathway in Proliferated Vascular Smooth Muscle from Diabetic Mice: Possible Role in High-Glucose-Induced Atherogenic Process
Journal of Diabetes Research
title Alteration of Mevalonate Pathway in Proliferated Vascular Smooth Muscle from Diabetic Mice: Possible Role in High-Glucose-Induced Atherogenic Process
title_full Alteration of Mevalonate Pathway in Proliferated Vascular Smooth Muscle from Diabetic Mice: Possible Role in High-Glucose-Induced Atherogenic Process
title_fullStr Alteration of Mevalonate Pathway in Proliferated Vascular Smooth Muscle from Diabetic Mice: Possible Role in High-Glucose-Induced Atherogenic Process
title_full_unstemmed Alteration of Mevalonate Pathway in Proliferated Vascular Smooth Muscle from Diabetic Mice: Possible Role in High-Glucose-Induced Atherogenic Process
title_short Alteration of Mevalonate Pathway in Proliferated Vascular Smooth Muscle from Diabetic Mice: Possible Role in High-Glucose-Induced Atherogenic Process
title_sort alteration of mevalonate pathway in proliferated vascular smooth muscle from diabetic mice possible role in high glucose induced atherogenic process
url http://dx.doi.org/10.1155/2015/379287
work_keys_str_mv AT guopingchen alterationofmevalonatepathwayinproliferatedvascularsmoothmusclefromdiabeticmicepossibleroleinhighglucoseinducedatherogenicprocess
AT xiaoqinzhang alterationofmevalonatepathwayinproliferatedvascularsmoothmusclefromdiabeticmicepossibleroleinhighglucoseinducedatherogenicprocess
AT taowu alterationofmevalonatepathwayinproliferatedvascularsmoothmusclefromdiabeticmicepossibleroleinhighglucoseinducedatherogenicprocess
AT liangli alterationofmevalonatepathwayinproliferatedvascularsmoothmusclefromdiabeticmicepossibleroleinhighglucoseinducedatherogenicprocess
AT jiehan alterationofmevalonatepathwayinproliferatedvascularsmoothmusclefromdiabeticmicepossibleroleinhighglucoseinducedatherogenicprocess
AT changqingdu alterationofmevalonatepathwayinproliferatedvascularsmoothmusclefromdiabeticmicepossibleroleinhighglucoseinducedatherogenicprocess